Related Experiment Video
Updated: Jan 8, 2026

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
Segregating pneumonia into pneumotypes.
Anne E D'Armond1, Jay K Kolls1
1Departments of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Researchers identified distinct lung microbial states, termed "pneumotypes," in pneumonia patients. These pneumotypes may predict patient outcomes and treatment effectiveness.
Area of Science:
- Microbiology
- Pulmonary Medicine
- Systems Biology
Background:
- Pneumonia is a significant cause of morbidity and mortality worldwide.
- The lung microbiome's role in pneumonia pathogenesis is increasingly recognized.
- Understanding microbial heterogeneity in the lung is crucial for effective treatment.
Purpose of the Study:
- To define distinct microbial states (pneumotypes) in the lungs of pneumonia patients.
- To investigate the association between pneumotypes and clinical outcomes.
- To explore the potential of pneumotypes for predicting therapeutic success.
Main Methods:
- Multi-omics analysis (e.g., metagenomics, metatranscriptomics) of bronchoalveolar lavage fluid.
- Bioinformatic approaches to cluster microbial profiles.
- Correlation analysis with clinical data, including disease severity and treatment response.
Main Results:
- Identification of several distinct pneumotypes characterized by specific microbial compositions and functions.
- Significant differences in clinical outcomes and treatment responses were observed across different pneumotypes.
- Certain pneumotypes were associated with poorer prognosis and reduced therapeutic efficacy.
Conclusions:
- Lung microbial states (pneumotypes) represent a novel way to classify pneumonia.
- Pneumotypes offer potential as biomarkers for predicting clinical trajectories and guiding therapeutic strategies.
- Further research is warranted to validate these findings and translate them into clinical practice.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

